Loading
A phase 2/3 trial of JMT101, docetaxel and HB1801 in lung cancer, run by Shanghai JMT-Bio Inc., not yet recruiting.
Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer is a phase 2/3, randomised interventional study registered as NCT06319313 by Shanghai JMT-Bio Inc., with a registry enrolment figure of 534 participants, started 2024-05-01 and due to reach its primary completion in 2026-07-01. Interventions recorded: JMT101; docetaxel; HB1801. Conditions listed: Squamous Cell Non-small Cell Lung Cancer. Primary outcome: Overall response rate (ORR); Overall Survival (OS); Incidence and severity of adverse events (AE) and serious adverse events (SAE). Lung eligibility wording from the registry: "Pathological diagnosis as sqNSCLC, with EGFR highly expressed, without other driver genes". No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Squamous cell carcinoma of the lung, Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Squamous cell carcinoma of the lung, Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Squamous cell carcinoma of the lung, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Squamous cell carcinoma of the lung, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Squamous cell carcinoma of the lung, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Squamous cell carcinoma of the lung, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/